Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Neoplasms; Prostatic Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Ovarian Neoplasms | Phase 3 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell | Phase 2 | ClinicalTrials |
| Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms | Phase 3 | ClinicalTrials |
| Fallopian Tube Neoplasms; Peritoneal Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung; Lung Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma; Colonic Neoplasms; Colorectal Neoplasms; Gastrointestinal Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell | Phase 2 | ClinicalTrials |
| Kidney Diseases; Renal Insufficiency | Phase 1 | ClinicalTrials |
| Breast Neoplasms | Phase 2 | ClinicalTrials |
| Neoplasms | Phase 1 | ClinicalTrials |
| Carcinoma; Carcinoma, Transitional Cell | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Hepatocellular | Phase 2 | ClinicalTrials |
CONTENTS